Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 200815-49-2
2. Brovana
3. (r,r)-arformoterol Tartrate
4. Arformoterol Tartrate [usan]
5. 5p8vj2i235
6. Arformoterol Tartrate (usan)
7. Formamide, N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
8. (r,r)-formoterol Tartrate
9. (-)-n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide Hydrogen (2r,3r)-2,3-dihydroxybutanedioate (salt)
10. Formamide, N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
11. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
12. Brovana Inhalation Solution
13. Unii-5p8vj2i235
14. Brovana (tn)
15. Arformotero Ltartrate
16. Dtxsid80173903
17. Arformoterol Tartrate [vandf]
18. S5217
19. Arformoterol Tartrate [mart.]
20. Akos005145740
21. Arformoterol Tartrate [who-dd]
22. Ccg-269651
23. Arformoterol Tartrate, >=98% (hplc)
24. Ba171831
25. Bs-42158
26. Arformoterol Tartrate [orange Book]
27. Formoterol R,r-form L-tartrate [mi]
28. D02981
29. 815f492
30. Q-101035
31. Q27262686
32. (2r,3r)-2,3-dihydroxybutanedioic Acid;n-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
33. (r,r)-formoterol Tartrate; N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1)
34. [(2r)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2r)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate
35. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutane Dioate
36. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutanedioate
37. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate
Molecular Weight | 494.5 g/mol |
---|---|
Molecular Formula | C23H30N2O10 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 11 |
Exact Mass | 494.19004516 g/mol |
Monoisotopic Mass | 494.19004516 g/mol |
Topological Polar Surface Area | 206 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 521 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Brovana |
PubMed Health | Arformoterol (By breathing) |
Drug Classes | Bronchodilator |
Active Ingredient | Arformoterol tartrate |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.015mg base/2ml |
Market Status | Prescription |
Company | Sunovion |
2 of 2 | |
---|---|
Drug Name | Brovana |
PubMed Health | Arformoterol (By breathing) |
Drug Classes | Bronchodilator |
Active Ingredient | Arformoterol tartrate |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.015mg base/2ml |
Market Status | Prescription |
Company | Sunovion |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?